Legal Representation
Attorney
Robert L. Powley
USPTO Deadlines
Next Deadline
785 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-09-12)
Due Date
September 12, 2027
Grace Period Ends
March 12, 2028
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 12, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Dec 12, 2023 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Dec 12, 2023 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Sep 12, 2023 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Sep 12, 2022 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Sep 12, 2017 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 8, 2017 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 7, 2017 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 18, 2017 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 17, 2017 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 19, 2017 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 19, 2017 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 3, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 8, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 8, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 19, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 26, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 23, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 18, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances [ ; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation ]
First Use Anywhere:
Mar 15, 2017
First Use in Commerce:
Mar 15, 2017
Classification
International Classes
005